Jo Anne Goldman

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

Michel Azizi, Kintur Sanghvi, Manish Saxena et al. · The Lancet · 2021 · 375 citations · Full text

Hypertension, Urology, Renal Function +9

Safety of a non-viral plasmid-encoding dual isoforms of hepatocyte growth factor in critical limb ischemia patients: a phase I study

Timothy D. Henry, A T Hirsch, Jo Anne Goldman et al. · Gene Therapy · 2011 · 76 citations

Hepatocyte Growth Factor, Hepatology, Liver Physiology +6

Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program

Michel Azizi, Andrew Sharp, Naomi D.L. Fisher et al. · Circulation · 2023 · 33 citations · Full text

Outcomes Related to Antiplatelet or Anticoagulation Use in Patients Undergoing Carotid Endarterectomy

Andrew Rosenbaum, Adnan Z. Rizvi, Peter Alden et al. · Annals of Vascular Surgery · 2010 · 30 citations

Thrombosis, Carotid Artery Surgery, Cardiovascular Disease +12

Long-term safety of intramuscular gene transfer of non-viral FGF1 for peripheral artery disease

Andreas Niebuhr, Timothy D. Henry, Jo Anne Goldman et al. · Gene Therapy · 2011 · 27 citations

Regenerative Medicine, Translational Medicine, Angiogenesis +13